SEC filing
SEC Concludes CareDx Investigation, Recommends No Enforcement Action
The SEC informed CareDx in a letter that it had concluded an investigation into the company's accounting and public reporting practices.
SEC Investigating Illumina Over Grail Acquisition
Illumina said the SEC has requested documents, including records "related to the conduct and compensation of certain members of Illumina and Grail management."
Cue Health Files for IPO for up to $100M
The company developed its portable Cue Integrated Care Platform for molecular SARS-CoV-2 testing and received an EUA for its test in June 2020.
Meridian LeadCare Business Undergoes FDA Inspection, Product Recall
The firm's Magellan business originally received a warning letter from the agency in 2017 regarding failure to submit medical device reports.
Sophia Genetics Increases IPO Target to $221M
The company will now offer 13 million common shares at $17 to $19 per share, raising its proceeds target from the previously announced $100 million.